Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
The Annals of Thoracic Surgery
|
August 31, 2000
Antiplatelet agents in cardiology: the choice of therapy
S R Steinhubl
Journal of Thrombosis and Thrombolysis
|
March 23, 2000
Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study
S R Steinhubl
Heart (British Cardiac Society)
|
January 10, 1998
Antithrombotic therapy with intracoronary stenting
S R Steinhubl, A M Lincoff
Journal of Thrombosis and Thrombolysis
|
September 27, 2000
Clopidogrel and coronary stenting: what is the next question?
S A Moore, S R Steinhubl
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting
S R Steinhubl, E J Topol
Lancet (London, England)
|
August 23, 1997
Stenting for acute myocardial infarction
S R Steinhubl, E J Topol
Heart and Vessels
|
January 1, 1997
Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina
S R Steinhubl, D J Moliterno
Journal of Thrombosis and Haemostasis : JTH
|
February 11, 2005
Variability in response to aspirin: do we understand the clinical relevance?
C L Campbell, S R Steinhubl
Annals of Medicine
|
December 29, 2000
Antiplatelet medications and their indications in preventing and treating coronary thrombosis
E Van De Graaff, S R Steinhubl
Current Cardiology Reports
|
August 16, 2001
Complications of oral antiplatelet medications
E Van De Graaff, S R Steinhubl
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
The Annals of Thoracic Surgery
|
August 31, 2000
Antiplatelet agents in cardiology: the choice of therapy
S R Steinhubl
Journal of Thrombosis and Thrombolysis
|
March 23, 2000
Assessing the optimal level of platelet inhibition with GPIIb/IIIa inhibitors in patients undergoing coronary intervention. Rationale and design of the GOLD study
S R Steinhubl
Heart (British Cardiac Society)
|
January 10, 1998
Antithrombotic therapy with intracoronary stenting
S R Steinhubl, A M Lincoff
Journal of Thrombosis and Thrombolysis
|
September 27, 2000
Clopidogrel and coronary stenting: what is the next question?
S A Moore, S R Steinhubl
Journal of Thrombosis and Thrombolysis
|
June 22, 1999
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting
S R Steinhubl, E J Topol
Lancet (London, England)
|
August 23, 1997
Stenting for acute myocardial infarction
S R Steinhubl, E J Topol
Heart and Vessels
|
January 1, 1997
Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina
S R Steinhubl, D J Moliterno
Journal of Thrombosis and Haemostasis : JTH
|
February 11, 2005
Variability in response to aspirin: do we understand the clinical relevance?
C L Campbell, S R Steinhubl
Annals of Medicine
|
December 29, 2000
Antiplatelet medications and their indications in preventing and treating coronary thrombosis
E Van De Graaff, S R Steinhubl
Current Cardiology Reports
|
August 16, 2001
Complications of oral antiplatelet medications
E Van De Graaff, S R Steinhubl
Page
of 3